Enstilar在哪里买比较靠谱？

Enstilar is a specific drug for the treatment of plaque psoriasis. Its purchasing channels, launch progress and price information are the issues that patients are most concerned about. Since the drug has not yet been officially launched in China, how to purchase genuine products through formal channels has become a problem for many patients. This article will introduce in detail Enstilar’s ​​reliable purchase channels, global availability and latest price information to help patients safely obtain this treatment drug.

Where to buy Enstilar more reliably

Since Enstilar has not yet been approved for marketing in China, patients need to purchase it through special channels. The following are several common and reliable purchasing methods.

Direct mail from international pharmacies

It is a safer way to choose an international pharmacy that has a cooperative relationship with LEO Pharma for direct mail. Patients can log in to the LEO Pharma official website to check the list of authorized international pharmacies. These pharmacies can provide genuine guarantee and complete cold chain transportation services. A valid doctor's prescription and identification are required when purchasing.

Cross-border medical platform

Some formal cross-border medical platforms provide Enstilar’s ​​drug purchase services. These platforms usually cooperate with overseas medical institutions to ensure the authenticity of the drugs. It is recommended to choose a platform endorsed by physical medical institutions and verify its drug import qualifications.

Purchasing medicine overseas

Patients who have the conditions may consider going to dermatology departments of hospitals in listed countries (such as the United States and European countries) and purchase it at local pharmacies with a formal prescription. Although this method is more expensive, it can ensure drug quality and medication guidance to the greatest extent.

Choose regular channels to purchase Enstilar, which can effectively avoid the risk of counterfeit drugs and ensure the best treatment effect.

Enstilar’s ​​launch status

Understanding the launch progress of Enstilar globally and in China will help patients determine when they can obtain the drug through formal channels.

Global marketing overview

Enstilar was approved for marketing by the US FDA in October 2015, and was subsequently approved in many countries and regions such as the European Union, Canada, and Australia. It is currently on the market in more than 50 countries around the world and is mainly used for the treatment of plaque psoriasis in adults over 18 years old.

China Approval Progress

Leo Pharma submitted a marketing application to the Chinese Food and Drug Administration in January 2024. Phase III clinical trials in China have been completed before, but it has not yet been officially launched and is expected to be approved within a few years.

Following the approval status of Enstilar in China can help patients rationally plan treatment time and drug purchase plans.

The price of Enstilar

The price of Enstilar varies depending on purchase channels and regions. The following is an analysis of the latest price information in 2025.

Official pricing

The price of Enstilar produced by LEO Pharma in Norway is US$188/box (2 bottles*60g). This price remains stable in major global markets, but will be adjusted based on local tax policies.

Treatment cost estimate

The standard treatment regimen (once a day for 4 weeks) usually requires 2 boxes of medication, with a total cost of approximately US$376.

Understanding the price structure and treatment costs of Enstilar can help patients choose the most suitable drug purchase method and economic plan according to their own circumstances.